Target intelligence / Profile preview

Lipopolysaccharide O:2 antigen (LPS O:2)

Target
LPS O:2
Molecular classification
Polysaccharide, Bacterial surface antigen, Endotoxin component
01

Overview

Lipopolysaccharide O:2 antigen is a specific polysaccharide component found on the outer membrane of certain Gram-negative bacteria, most notably Salmonella enterica serovar Paratyphi A (PubMed: 25644322). As part of the lipopolysaccharide (LPS) complex, the O:2 antigen serves as the outermost domain, playing a critical role in protecting the bacterium from host immune defenses and environmental stress (NCBI: NBK7907). It is a primary target for the host's humoral immune response, making it a significant focus for vaccine development and diagnostic serotyping (PubMed: 30216179). In clinical settings, the O:2 antigen is used to identify specific bacterial strains associated with enteric fever, urinary tract infections, and other systemic infections (PubMed: 11516411). Therapeutic strategies targeting this molecule often involve the use of glycoconjugate vaccines or monoclonal antibodies designed to promote opsonophagocytosis and pathogen clearance (PubMed: 28838618). Understanding the structure and variability of the O:2 antigen is essential for managing outbreaks and developing effective antimicrobial interventions.

Other names
O2 antigenO-antigen 2Salmonella Paratyphi A O-antigenGroup A O-antigenE. coli O2 antigen
02

Mechanism of action

Induction of serotype-specific bactericidal antibodies and opsonophagocytosis to neutralize the pathogen (PubMed: 28838618).

03

Biological functions

Bacterial cell wall integrityImmune responsePathogenicityHost-pathogen interaction
04

Disease associations

Enteric feverSalmonellosisUrinary tract infectionSepsis
05

Safety considerations

Endotoxicity risk from Lipid A contaminationJarisch-Herxheimer reactionLimited cross-reactivity with other serotypes
06

Interacting drugs

Salmonella Paratyphi A glycoconjugate vaccine

2 more in the full profile.

07

Biomarkers

Anti-O:2 IgG titersAnti-O:2 IgM titersO:2 serotyping

Beyond the preview

Go deeper on Lipopolysaccharide O:2 antigen (LPS O:2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipopolysaccharide O:2 antigen (LPS O:2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call